Southern Oncology Clinical Research Unit is a phase one cancer trials unit based in Adelaide, South Australia. It provides patients the opportunity to participate in ongoing cancer research while receiving clinical care from skilled health professionals. The unit conducts trials using various interventions including cytotoxic, targeted therapies, immunotherapy, and oncolytic viral therapies.

Southern Oncology Clinical Research Unit

Scientia Clinical Research conducts clinical trials and invites participants to join these trials.

Scientia Clinical Research

Southern Oncology South Australia provides specialists medical oncology services focused on patient care.

Southern Oncology South Australia

Avance Clinical is a full-service Contract Research Organization (CRO) that specializes in delivering clinical drug development services for international biotechs. The company has a world-class reputation for quality data and offers a range of in-house clinical services, including pre-clinical services, clinical monitoring management, data management, eClinical solutions, safety and pharmacovigilance, medical writing, project management, statistics and pharmacokinetics, and quality assurance.

Metric
Company Name	Southern Oncology Clinical Research Unit	Scientia Clinical Research	Southern Oncology South Australia	Avance Clinical
Symbol
MSH ID	AU:ORG:SOCRU	AU:COM:SCIENTIACLINICALRESEARCH	AU:NET:SOSA	COM:AVANCECRO
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Research	Clinical Research	Healthcare	Healthcare & Health Services
Country	AU	AU	AU
Stage
Employee Count				101
Website	socru.org.au	scientiaclinicalresearch.com.au	sosa.net.au	avancecro.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ORG

AU:ORG:SOCRU

Southern Oncology Clinical Research Unit

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue